, Volume 12, Issue 3, pp 466–469 | Cite as

Family history in the diagnosis of monogenic diabetes “leads and misleads”

  • Cristina Colom
  • Josep Oriola
  • Silvia Martinez
  • Francisco Blanco-Vaca
  • Roser Casamitjana
  • Rosa Corcoy
Case report


Always granting that de novo mutations are possible, family history and biological characteristics are nonetheless crucial for the diagnosis of monogenic diabetes. We report here the case of two patients with monogenic diabetes in which the initial family history misled the diagnostic work-up and did not support the diagnosis. Family history details changed substantially after the molecular diagnosis was established.

Key words

Family history Glucokinase Hepatic nuclear factor-1β Monogenic diabetes 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yki-Järvinen H, 1994. Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 343: 91–95.CrossRefPubMedGoogle Scholar
  2. 2.
    Barnett AH, Eff C, Leslie RD, Pyke DA, 1981 Diabetes in identical twins: a study of 200 pairs. Diabetologia 20: 87–93.CrossRefPubMedGoogle Scholar
  3. 3.
    Redondo MJ, Yu L, Hawa M, et al, 2001 Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44: 354–362.CrossRefPubMedGoogle Scholar
  4. 4.
    Kaprio J, Tuomilehto J, Koskenvuo M, et al, 1992 Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35: 1060–1067.CrossRefPubMedGoogle Scholar
  5. 5.
    Frayling TM, Evans JC, Bulman MP, et al, 2001 Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50: Suppl 1: 94–100.CrossRefGoogle Scholar
  6. 6.
    Ledermann HM, 1995 Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet 345: 648.CrossRefPubMedGoogle Scholar
  7. 7.
    Ellard S, Bellanne-Chantelot C, Hattersley AT, 2008 Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51: 546–553.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Colom C, Corcoy R, 2010 Maturity onset diabetes of the young and pregnancy. Best Pract Res Clin Endocrinol Metab 24: 605–615.CrossRefPubMedGoogle Scholar
  9. 9.
    Pearson ER, Boj SF, Steele AM, et al, 2007 Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLos Med 4: e 118.CrossRefGoogle Scholar
  10. 10.
    Bellanné-Chantelot C, Chauveau D, Gautier JF, et al, 2004 Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann intern Med 140: 510–517.CrossRefPubMedGoogle Scholar
  11. 11.
    Zaffanello M, Brugnara M, Franchini M, et al, 2008 VTCF2 gene mutation leads to nephro-urological defects of unequal severity: an open question. Med Sci Monit 14: RA78–86.PubMedGoogle Scholar
  12. 12.
    Yorifuji T, Kurokawa K, Mamada M, et al, 2004 Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism. J Clin Endocrinol Metab 89: 2905–2908.CrossRefPubMedGoogle Scholar
  13. 13.
    Heidet L, Decramer S, Pawtowski A, et al, 2010 Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol 5: 1079–1090.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    De Las Heras J, Martinez R, Rica I, et al, 2010 Heterozygous glucokinase mutations and birth weight in Spanish children. Diabet Med 27: 608–610.CrossRefPubMedGoogle Scholar
  15. 15.
    Barrio R, Bellanné-Chantelot C, Moreno JC, et al, 2002 Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 87: 2532–2539.CrossRefPubMedGoogle Scholar
  16. 16.
    Estalella I, Rica I, Perez de Nanclares G, et al, 2007 Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. Clin Endocrinol (Oxf) 67: 538–546.Google Scholar
  17. 17.
    Shields BM, Spyer G, Slingerland AS, et al, 2008 Mutations in the glucokinase gene of the fetus result in reduced placental weight. Diabetes Care 31: 753–757.CrossRefPubMedGoogle Scholar
  18. 18.
    Shields BM, McDonald TJ, Ellard S, et al, 2012 The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55: 1265–1272.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2013

Authors and Affiliations

  • Cristina Colom
    • 1
  • Josep Oriola
    • 2
  • Silvia Martinez
    • 3
  • Francisco Blanco-Vaca
    • 3
    • 4
    • 5
  • Roser Casamitjana
    • 2
  • Rosa Corcoy
    • 1
    • 6
    • 7
  1. 1.Servei d’Endocrinologia i NutriciöHospital de la Santa Creu i Sant PauBarcelonaSpain
  2. 2.Servei de Bioquímica i Genètica Molecular (CDB), Institut d’Investigacions Biomèdiques August Pi i SunyerHospital Clinic i UniversitariBarcelonaSpain
  3. 3.Servei de Bioquimica ClinicaHospital de la Santa Creu i Sant PauBarcelonaSpain
  4. 4.Departament de Bioquímica i Biologia MolecularUniversitat Autònoma de BarcelonaBarcelonaSpain
  5. 5.CIBERDEMInstituto de Salud Carlos IIIMadridSpain
  6. 6.Departament de MedicinaUniversitat Autònoma de BarcelonaBarcelonaSpain
  7. 7.CIBER Bioengineering, Biomaterials and NanotechnologyInstituto de Salud Carlos IIIMadridSpain

Personalised recommendations